News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
JeeSuk Chang: Yonsei, single institution report of S-PBI now in press
Photo taken from JeeSuk Chang/X
Dec 30, 2023, 04:04

JeeSuk Chang: Yonsei, single institution report of S-PBI now in press

JeeSuk Chang, , shared on X/Twitter:

“Yonsei, single institution report of S-PBI now in press.

  • PBI use remains low
  • This contrast with the growing adoption of hypo-WBI, especially after Fast-forward
  • how to optimally position both 5-fx

– 815 S-PBI
– Breast V50, 32.3%
– MLD 2.5Gy, MHD 0.65 Gy
– Low acute toxicity (21.5%)

Comparison with 476 FF-WBI: similarly low toxicity, reduced OAR dose in S-PBI.

External PBI with advanced tech should at least be considered over WBI approaches for PBI candidates.

JeeSuk Chang: Yonsei, single institution report of S-PBI now in press

Huge thanks to Dr. Frank Vicini for kickstarting this research project and for his guidance.
Also, shoutout to our Yonsei colleagues, Jin Sung Kim, Jihun Kim, Yong Bae Kim, Jeongshim Lee, Seo Hee Choi, Ik Jae Lee. ”

Proceed to the article.
Source: JeeSuk Chang/X

Breast Cancer cancer Frank Vicini Ik Jae Lee in Sung Kim JeeSuk Chang Jeongshim Lee Jihun Kim OncoDaily Oncology radiation oncology Seo Hee Choi Yong Bae Kim Yonsei University Health System
Special Coverage
Science
Jan 19, 2025, 07:52
Paolo Tarantino: What’s distinct about Breast cancers with ERBB2?
Science
Jan 19, 2025, 07:45
Cristiane Bergerot: Mindfulness via smartphone
Science
Jan 19, 2025, 07:42
Xiuning Le: The number of newly diagnosed female lung cancer cases has surpassed that of males
Insight
Jan 19, 2025, 07:37
Stephanie Graff: Excited to have another therapeutic option to treat advanced HR+ breast cancer
Dialogues
Jan 19, 2025, 07:33
The Experience of Colorectal Cancer Screening in Kazakhstan
Science
Jan 19, 2025, 07:29
Melissa Loh: Protocol paper on our multicenter UR-GOAL study
Science
Jan 19, 2025, 07:26
Emre Yekedüz: Happy to share our studies at ASCO GU25
Science
Jan 19, 2025, 07:23
The incidence of GEP-NETs in the US
Science
Jan 19, 2025, 07:17
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer
Science
Jan 19, 2025, 07:02
Erman Akkus: Understanding the BRAF pathway
Science
Jan 19, 2025, 06:59
Paolo Tarantino: A new ADC is now available to treat the most common subtype of breast cancer
Science
Jan 19, 2025, 06:56
Pashtoon Kasi: One more option for our patients with Colorectal Cancer